Product
Topical Vehicle
1 clinical trial
2 indications
Indication
Vascular MalformationsIndication
lymphatic malformationClinical trial
0.1% Topical Sirolimus in the Treatment of Cutaneous Microcystic Lymphatic Malformations in Children and Adults: Phase II, Split-body Randomized, Double-blind, Vehicle-controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2023-09-01